JP2009511084A5 - - Google Patents

Download PDF

Info

Publication number
JP2009511084A5
JP2009511084A5 JP2008536796A JP2008536796A JP2009511084A5 JP 2009511084 A5 JP2009511084 A5 JP 2009511084A5 JP 2008536796 A JP2008536796 A JP 2008536796A JP 2008536796 A JP2008536796 A JP 2008536796A JP 2009511084 A5 JP2009511084 A5 JP 2009511084A5
Authority
JP
Japan
Prior art keywords
influenza
vaccine
proteins
influenza virus
vlp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008536796A
Other languages
English (en)
Japanese (ja)
Other versions
JP5714799B2 (ja
JP2009511084A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/040862 external-priority patent/WO2007047831A2/en
Publication of JP2009511084A publication Critical patent/JP2009511084A/ja
Publication of JP2009511084A5 publication Critical patent/JP2009511084A5/ja
Application granted granted Critical
Publication of JP5714799B2 publication Critical patent/JP5714799B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008536796A 2005-10-18 2006-10-18 機能的インフルエンザウイルス様粒子(vlp) Active JP5714799B2 (ja)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US72751305P 2005-10-18 2005-10-18
US60/727,513 2005-10-18
US78084706P 2006-03-10 2006-03-10
US60/780,847 2006-03-10
US80000606P 2006-05-15 2006-05-15
US60/800,006 2006-05-15
US83119606P 2006-07-17 2006-07-17
US60/831,196 2006-07-17
US83211606P 2006-07-21 2006-07-21
US60/832,116 2006-07-21
US84549506P 2006-09-19 2006-09-19
US60/845,495 2006-09-19
PCT/US2006/040862 WO2007047831A2 (en) 2005-10-18 2006-10-18 Functional influenza virus like particles (vlps)

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2012115616A Division JP5771558B2 (ja) 2005-10-18 2012-05-21 機能的インフルエンザウイルス様粒子(vlp)
JP2015016492A Division JP2015083018A (ja) 2005-10-18 2015-01-30 機能的インフルエンザウイルス様粒子(vlp)

Publications (3)

Publication Number Publication Date
JP2009511084A JP2009511084A (ja) 2009-03-19
JP2009511084A5 true JP2009511084A5 (enExample) 2009-12-03
JP5714799B2 JP5714799B2 (ja) 2015-05-07

Family

ID=37963272

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2008536796A Active JP5714799B2 (ja) 2005-10-18 2006-10-18 機能的インフルエンザウイルス様粒子(vlp)
JP2012115616A Active JP5771558B2 (ja) 2005-10-18 2012-05-21 機能的インフルエンザウイルス様粒子(vlp)
JP2015016492A Withdrawn JP2015083018A (ja) 2005-10-18 2015-01-30 機能的インフルエンザウイルス様粒子(vlp)
JP2016088847A Withdrawn JP2016135142A (ja) 2005-10-18 2016-04-27 機能的インフルエンザウイルス様粒子(vlp)
JP2017144662A Pending JP2017189178A (ja) 2005-10-18 2017-07-26 機能的インフルエンザウイルス様粒子(vlp)

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2012115616A Active JP5771558B2 (ja) 2005-10-18 2012-05-21 機能的インフルエンザウイルス様粒子(vlp)
JP2015016492A Withdrawn JP2015083018A (ja) 2005-10-18 2015-01-30 機能的インフルエンザウイルス様粒子(vlp)
JP2016088847A Withdrawn JP2016135142A (ja) 2005-10-18 2016-04-27 機能的インフルエンザウイルス様粒子(vlp)
JP2017144662A Pending JP2017189178A (ja) 2005-10-18 2017-07-26 機能的インフルエンザウイルス様粒子(vlp)

Country Status (19)

Country Link
EP (1) EP1937301B1 (enExample)
JP (5) JP5714799B2 (enExample)
KR (1) KR101359723B1 (enExample)
CN (2) CN101325966B (enExample)
AU (1) AU2006304640B2 (enExample)
BR (1) BRPI0617486A2 (enExample)
CA (1) CA2625406C (enExample)
DK (1) DK1937301T3 (enExample)
ES (1) ES2543056T3 (enExample)
HU (1) HUE026136T2 (enExample)
IL (1) IL190775A (enExample)
NZ (1) NZ567164A (enExample)
PL (1) PL1937301T3 (enExample)
PT (1) PT1937301E (enExample)
RU (1) RU2483751C2 (enExample)
SG (1) SG2014012868A (enExample)
SI (1) SI1937301T1 (enExample)
TW (1) TWI488968B (enExample)
WO (1) WO2007047831A2 (enExample)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0250488A (ja) * 1988-08-11 1990-02-20 Nec Corp 超伝導配線
US8551756B2 (en) 2003-07-11 2013-10-08 Novavax, Inc. Avian influenza chimeric VLPS
US9101578B2 (en) 2006-05-01 2015-08-11 Technovax, Inc. Polyvalent influenza virus-like particle (VLP) compositions
US8778353B2 (en) 2006-05-01 2014-07-15 Technovax, Inc. Influenza virus-like particle (VLP) compositions
JP5683811B2 (ja) * 2006-07-27 2015-03-11 タケダ ヴァクシーンズ, インコーポレイテッド キメラインフルエンザウイルス様粒子
US8202967B2 (en) 2006-10-27 2012-06-19 Boehringer Ingelheim Vetmedica, Inc. H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
CA2615372A1 (en) 2007-07-13 2009-01-13 Marc-Andre D'aoust Influenza virus-like particles (vlps) comprising hemagglutinin
JP2010533737A (ja) * 2007-07-19 2010-10-28 ノババックス,インコーポレイテッド キメラ水痘帯状疱疹ウイルス−ウイルス様粒子
KR101255419B1 (ko) 2007-11-12 2013-04-17 이노비오 파마수티컬즈, 인크. 인플루엔자 바이러스의 다중 아형에 대한 신규 백신
NZ587108A (en) 2007-11-27 2013-04-26 Medicago Inc Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin
DK2294202T3 (en) 2008-07-08 2015-08-31 Medicago Inc SOLUBLE RECOMBINANT INFLUENZA ANTIGENES
KR101745925B1 (ko) * 2008-07-18 2017-06-12 메디카고 인코포레이티드 신규 인플루엔자 바이러스 면역화 에피토프
CN102271704A (zh) * 2008-11-28 2011-12-07 梅里亚有限公司 重组禽流感疫苗及其用途
AU2010243490A1 (en) * 2009-04-30 2011-11-24 Cytos Biotechnology Ag Influenza hemagglutinin compositions and uses thereof
JP2012525133A (ja) * 2009-05-01 2012-10-22 レッドバイオテック・アーゲー 多重遺伝子ベクターによってコードされる組換えウイルス様粒子
TW201738562A (zh) * 2009-05-28 2017-11-01 亞培生物股份有限公司 體外病原體檢驗技術
SI2445928T1 (en) 2009-06-24 2018-05-31 Medicago Inc. HYPER PARTICULARS, SIMILAR VIRUSES OF GRIPE, WHICH HAVE EXPOSED HEMAGLUTININE
SG178918A1 (en) 2009-09-22 2012-04-27 Medicago Inc Method of preparing plant-derived vlps
CA2789945A1 (en) * 2010-02-18 2011-08-25 Technovax, Inc. Universal virus-like particle (vlp) influenza vaccines
US10130697B2 (en) 2010-03-23 2018-11-20 Wisconsin Alumni Research Foundation (Warf) Vaccines comprising mutant attenuated influenza viruses
JP2012036154A (ja) * 2010-08-11 2012-02-23 Goshu Yakuhin Kk 食品
CN101947317B (zh) * 2010-09-27 2012-05-30 武汉大学 一种h5n1禽流感病毒样颗粒疫苗的规模化制备方法
US20140004146A1 (en) * 2011-03-17 2014-01-02 Institut Pasteur Of Shanghai, Chinese Academy Of Sciences Method for producing virus-like particle by using drosophila cell and applications thereof
TWI620816B (zh) 2011-03-23 2018-04-11 苜蓿股份有限公司 植物衍生蛋白回收方法
EA016866B1 (ru) * 2011-06-06 2012-08-30 Общество С Ограниченной Ответственностью "Форт" (Ооо "Форт") Вакцина для специфической профилактики гриппа
KR101302245B1 (ko) * 2011-06-27 2013-09-02 조지아 스테이트 유니버시티 리서치 파운데이션, 인코포레이티드 넓은 범위의 교차 방어능력을 갖는 신규한 보강 인플루엔자 백신
AR088028A1 (es) 2011-08-15 2014-05-07 Boehringer Ingelheim Vetmed Proteinas h5, de h5n1 para un uso medicinal
ES2655051T3 (es) 2011-08-26 2018-02-16 Wisconsin Alumni Research Foundation Virus de la gripe con segmento génico PB2 mutante como vacunas vivas atenuadas
JP5884100B2 (ja) * 2011-08-31 2016-03-15 公益財団法人東京都医学総合研究所 新型インフルエンザウイルス由来ヘマグルチニンタンパク質遺伝子を有するDIs株由来組換えワクシニアウイルス
TWI700368B (zh) * 2011-09-30 2020-08-01 苜蓿股份有限公司 增加植物類病毒顆粒產率
US11390878B2 (en) 2011-09-30 2022-07-19 Medicago Inc. Increasing protein yield in plants
US20150071987A1 (en) * 2012-02-03 2015-03-12 Emory University Immunostimulatory compositions, particles, and uses related thereto
RU2485973C1 (ru) * 2012-02-28 2013-06-27 Общество с ограниченной ответственностью "НТфарма" Рекомбинантная трехвалентная вакцина от гриппа человека
WO2014127825A1 (en) * 2013-02-21 2014-08-28 Boehringer Ingelheim Vetmedica Gmbh H5 proteins of h5n1 influenza virus for use as a medicament
US9649375B2 (en) * 2013-03-14 2017-05-16 The Administrators Of The Tulane Educational Fund Immunogenic peptide conjugate and method for inducing an anti-influenza therapeutic antibody response therewith
US12467058B2 (en) 2013-03-28 2025-11-11 Aramis Biotechnologies Inc. Influenza virus-like particle production in plants
JP2016516415A (ja) * 2013-03-28 2016-06-09 メディカゴ インコーポレイテッド 植物におけるインフルエンザウイルス様粒子の生成
BR112016015875A2 (pt) 2014-01-10 2017-09-19 Medicago Inc Elementos intensificadores de cpmv
CN103740655A (zh) * 2014-01-20 2014-04-23 瑞鑫百奥生物科技(深圳)有限公司 H5n1禽流感病毒样颗粒及其应用和制备方法、疫苗
AU2015234595B2 (en) 2014-03-27 2021-03-25 Medicago Inc. Modified CPMV enhancer elements
EP3157557A1 (en) * 2014-06-20 2017-04-26 The U.S.A. as represented by the Secretary, Department of Health and Human Services Polyvalent influenza virus-like particles (vlps) and use as vaccines
WO2015196150A2 (en) 2014-06-20 2015-12-23 Wisconsin Alumni Research Foundation (Warf) Mutations that confer genetic stability to additional genes in influenza viruses
EP3341018B1 (en) * 2015-08-28 2026-05-20 Wisconsin Alumni Res Found GENERATION OF INFECTIOUS INFLUENZA VIRUSES FROM VIRUS-LIKE PARTICLES
RU2639491C2 (ru) * 2015-08-31 2017-12-21 Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) Вирионы и вирусоподобные частицы вируса мозаики альтернантеры как усилители иммунного ответа
IL257800B2 (en) 2015-09-03 2023-11-01 Novavax Inc Immune compositions with improved stability and immunogenicity
CN109477074B (zh) 2016-02-19 2023-01-24 威斯康星旧生研究基金会 用于疫苗开发的改进的乙型流感病毒复制
CA3029629A1 (en) * 2016-04-18 2017-10-26 Emerging Viral Vaccine (HK) Limited Cold adapted and virulence factor deleted live attenuated vaccine suitable for mucosal delivery
EP4074734A1 (en) 2017-08-04 2022-10-19 The Hospital for Sick Children Nanoparticle platform for antibody and vaccine delivery
CN107353328A (zh) * 2017-08-23 2017-11-17 上海市动物疫病预防控制中心 一种重组的h9n2亚型禽流感病毒样颗粒及其制备方法和用途
CN110240634B (zh) * 2018-03-08 2022-09-06 普莱柯生物工程股份有限公司 一种禽流感病毒样颗粒疫苗、及其制备方法和应用
CN108409842A (zh) * 2018-03-15 2018-08-17 山东省农业科学院畜牧兽医研究所 一种单克隆抗体及其制备方法
JP7783047B2 (ja) 2018-08-07 2025-12-09 ウィスコンシン アルムニ リサーチ ファンデイション 組換えの生物学的に封じ込められたフィロウイルスワクチン
EP3840780A1 (en) 2018-08-20 2021-06-30 Wisconsin Alumni Research Foundation Vectors for eliciting immune responses to non-dominant epitopes in the hemagglutinin (ha) protein
WO2020163804A1 (en) 2019-02-08 2020-08-13 Wisconsin Alumni Research Foundation (Warf) Humanized cell line
CN114929269A (zh) 2019-05-01 2022-08-19 威斯康星校友研究基金会(Warf) 用于疫苗开发的改进的流感病毒复制
JP7627911B2 (ja) 2019-08-27 2025-02-07 ウィスコンシン アルムニ リサーチ ファンデイション 卵内複製のための安定化されたhaを持つ組換えインフルエンザウイルス
EP4093415A1 (en) 2020-01-24 2022-11-30 Wisconsin Alumni Research Foundation (WARF) Recombinant influenza viruses with stabilized na
KR20230013237A (ko) 2020-03-09 2023-01-26 다이나박스 테크놀로지 코퍼레이션 Tlr9 효능제를 포함하는 대상포진 백신
EP4129309A4 (en) * 2020-03-24 2023-11-01 Byung Chul Ahn Method for producing serum composition for preventing or treating mucosa-related infectious disease in young mammals, serum composition produced thereby, and use thereof
KR102151962B1 (ko) * 2020-03-24 2020-09-04 안병철 어린 포유동물의 전염성 질병을 예방 또는 치료하기 위한 혈청 조성물의 제조방법, 상기 방법에 의해 제조된 혈청 조성물 및 이의 용도
US12290562B2 (en) 2020-03-25 2025-05-06 Wisconsin Alumni Research Foundation (Warf) Recombinant multivalent influenza viruses
CN113461786B (zh) * 2020-03-30 2022-09-13 普莱柯生物工程股份有限公司 一种禽流感病毒样颗粒疫苗、及其制备方法和应用
MX2022013456A (es) 2020-05-01 2022-11-16 Sinocelltech Ltd Metodo para mejorar la inmunogenicidad de un antigeno proteinico/peptidico.
CN112342149A (zh) * 2020-11-12 2021-02-09 新疆畜牧科学院兽医研究所(新疆畜牧科学院动物临床医学研究中心) 一种禽流感病毒样颗粒组装表达系统及其应用
CN112979796A (zh) * 2021-04-27 2021-06-18 军事科学院军事医学研究院军事兽医研究所 马抗甲型h5n1虎源流感病毒免疫球蛋白和特异性免疫球蛋白及其精制方法
CN113862284B (zh) * 2021-09-13 2023-05-26 华南农业大学 一种编码重组禽流感病毒ha蛋白的基因、病毒样颗粒、疫苗及制备与应用
CN114262720B (zh) * 2021-12-27 2023-07-25 河南兴华生物技术有限公司 杆状病毒表达系统的信号肽及其应用
CN116554341A (zh) * 2022-01-29 2023-08-08 中国疾病预防控制中心病毒病预防控制所 一种人偏肺病毒病毒样颗粒、制备方法、应用及疫苗
CN116286884A (zh) * 2023-02-22 2023-06-23 扬州大学 Ha蛋白糖基化修饰模式改变的禽流感病毒样颗粒及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4866034A (en) 1982-05-26 1989-09-12 Ribi Immunochem Research Inc. Refined detoxified endotoxin
US4877611A (en) 1986-04-15 1989-10-31 Ribi Immunochem Research Inc. Vaccine containing tumor antigens and adjuvants
US4911928A (en) 1987-03-13 1990-03-27 Micro-Pak, Inc. Paucilamellar lipid vesicles
US6387373B1 (en) 1993-01-15 2002-05-14 Novavax, Inc. Vaccines containing paucilsmellar lipid vesicles as immunological adjuvants
US5629021A (en) 1995-01-31 1997-05-13 Novavax, Inc. Micellar nanoparticles
DK1294892T3 (da) * 2000-06-23 2008-01-28 Wyeth Corp Aggregering af vildtype- og kimære influenzaviruslignende partikler (VLP'er)
US7041500B2 (en) 2002-02-14 2006-05-09 Novavax, Inc. Insect cell line
US8592197B2 (en) * 2003-07-11 2013-11-26 Novavax, Inc. Functional influenza virus-like particles (VLPs)

Similar Documents

Publication Publication Date Title
RU2008119501A (ru) Функциональные вирусоподоюные частицы гриппа (vlps)
Zheng et al. Development of universal influenza vaccines based on influenza virus M and NP genes
JP2009539965A5 (enExample)
JP2004527264A5 (enExample)
Banzhoff et al. MF59®‐adjuvanted vaccines for seasonal and pandemic influenza prophylaxis
AR052625A1 (es) Nueva composicion
JP2011504486A5 (enExample)
RU2015132962A (ru) Иммуногенные композиции на основе вируса гриппа и их применение
JP2013216685A5 (enExample)
JP2016155867A5 (enExample)
JP2006527762A5 (enExample)
WO2009026397A3 (en) Prophylactic and therapeutic influenza vaccines, antigens, compositions, and methods
JP2005525085A5 (enExample)
WO2007124479A3 (en) Avian influenza viruses, vaccines, compositions, formulations, and methods
Budimir et al. Heterosubtypic cross‐protection induced by whole inactivated influenza virus vaccine in mice: influence of the route of vaccine administration
JP2017524682A5 (enExample)
RU2017137357A (ru) Быстрорастворяющаяся лекарственная форма пероральной вакцины, в которой используют крахмал
Kang et al. Novel vaccines against influenza viruses
JP2011515490A5 (enExample)
JP2018501258A5 (enExample)
Leung et al. An H5N1-based matrix protein 2 ectodomain tetrameric peptide vaccine provides cross-protection against lethal infection with H7N9 influenza virus
JP2010506926A5 (enExample)
JP2011057605A (ja) 粘膜投与型ワクチン
JP2009518410A5 (enExample)
JP2019534242A5 (enExample)